Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
AS.2NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.115NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
AY.127.1 (Delta)NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.88NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.423NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.550NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.261NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
XBB.3.5NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
EP.1.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BQ.1.15.2NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
XCBNWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
XBB.5NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BQ.1.15.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
CM.8.1.5NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
XSNWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
FL.4.7NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
XBB.1.5.29NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.38NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.5.2.40NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
XBB.1.5.74NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
XBB.7NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BN.2.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
XBB.2.6.2NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.238NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
XBB.1.7NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
XBB.1.11NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BQ.1.1.68NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BF.7.26NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BR.1.2NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BQ.1.1.25NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BQ.1.1.51NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
FT.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
XBB.2.11.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
EE.5NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BQ.1.1.52NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
XBF.9NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BN.1.4.5NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
DS.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.5.2.32NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BQ.1.1.58NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.627NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.519NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.514NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
GT.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
XBB.1.5.87NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
XAPNWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BE.1.4.3NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
XBB.2.6.3NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
XBB.1.47.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
XBF.2NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used